Stay on top of the latest headlines from the Wall Street Journal Online.
2k followers 15 artykułów/tydzień
What’s News in Markets: Weak Coffee, Advantage Lost, AI Push

Why did Starbucks’ latest earnings leave a bitter taste for some investors? And how did healthcare turn unhealthy for CVS? Plus, how did artificial intelligence boost Amazon and Apple? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Learn more about your ad choices. Visit megaphone.fm/adchoices

Sat May 4, 2024 13:10
Biden Seeks to Trump-Proof His Agenda

P.M. Edition for May 3. When Donald Trump was president, he used a 1996 law, the Congressional Review Act, to undo many of the regulations enacted by his predecessor. Now, President Biden is rushing to cement his legacy ahead of a likely rematch with Trump in November. Domestic policy correspondent Andrew Restuccia explains. And U.S. hiring slowed in...

Sat May 4, 2024 00:16
Governments Crack Down on Free Press, Copying the Kremlin

A.M. Edition for May 3. Governments around the globe have been making it harder for the media to provide reliable and independent news—including in Russia, where WSJ reporter Evan Gershkovich has been detained for more than a year. Plus, the U.S. reshuffles military assets in the Middle East after getting pushback from a Gulf partner wary of getting...

Fri May 3, 2024 13:31
Berkshire Hathaway Poised to Hit $1 Trillion Valuation

P.M. Edition for May 2. Berkshire Hathaway is nearing a milestone, as thousands of investors and onlookers gather for its annual shareholder meeting this weekend. Markets reporter Karen Langley has more. And Sony and Apollo make a $26 billion, all-cash offer for Paramount. Plus, cleanup begins at UCLA after violent clashes between police and protesters....

Fri May 3, 2024 00:03
Can Ozempic Maker Novo Nordisk Keep Up Its Momentum?

A.M. Edition for May 2. Danish pharmaceutical giant Novo Nordisk upped its full-year guidance today as it reported continued strong demand for its blockbuster weight-loss and diabetes drugs. Barclays analyst Emily Field discusses where the drugmaker could go from here. Plus, Exxon Mobil reaches an agreement to close its $60 billion merger with Pioneer....

Thu May 2, 2024 13:20
Can Ozempic Maker Novo Nordisk Keep Up Its Momentum?

A.M. Edition for May 2. Danish pharmaceutical giant Novo Nordisk upped its full-year guidance today as it reported continued strong demand for its blockbuster weight-loss and diabetes drugs. Barclays analyst Emily Field discusses where the drugmaker could go from here. Plus, Exxon Mobil reaches an agreement to close its $60 billion merger with Pioneer....

Thu May 2, 2024 13:10

Zbuduj własny kanał informacyjny

Gotowy, by spróbować?
Rozpocznij 14-dniowy okres próbny, karta kredytowa nie jest wymagana.

Załóż konto